Product NDC: | 67979-002 |
Proprietary Name: | SUPPRELIN |
Non Proprietary Name: | histrelin acetate |
Active Ingredient(s): | 50 mg/1 & nbsp; histrelin acetate |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | IMPLANT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67979-002 |
Labeler Name: | Endo Pharmaceuticals Solutions Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022058 |
Marketing Category: | NDA |
Start Marketing Date: | 20070531 |
Package NDC: | 67979-002-01 |
Package Description: | 1 VIAL, GLASS in 1 CARTON (67979-002-01) > 1 IMPLANT in 1 VIAL, GLASS |
NDC Code | 67979-002-01 |
Proprietary Name | SUPPRELIN |
Package Description | 1 VIAL, GLASS in 1 CARTON (67979-002-01) > 1 IMPLANT in 1 VIAL, GLASS |
Product NDC | 67979-002 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | histrelin acetate |
Dosage Form Name | IMPLANT |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20070531 |
Marketing Category Name | NDA |
Labeler Name | Endo Pharmaceuticals Solutions Inc. |
Substance Name | HISTRELIN ACETATE |
Strength Number | 50 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA] |